Exclusive special offer and discount title banner vector image

GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST 2023-2032

SCOPE OF THE REPORT

Global Pharmaceutical Supply Chain Management Market by Component (Solution (Transportation Management System, Planning & Analytics, Warehouse & Inventory Management System, Procurement & Sourcing, Manufacturing Execution System), Service (Professional Services, Managed Services)) Market by Deployment Mode (on-premise, Cloud-based) by Geography


MARKET OVERVIEW

The global pharmaceutical supply chain management market was valued at $2302.87 million in 2022 and is expected to reach $5289.53 million by 2032, growing at a CAGR of 8.84% during the forecast years. The base year considered for the study is 2022, and the estimated period is between 2022 and 2032. The market study has also analyzed the impact of COVID-19 on the global pharmaceutical supply chain management market qualitatively as well as quantitatively.

Pharmaceutical supply chain management involves the coordination and control of the movement of pharmaceutical products from their source to the final destination. This is where pharmaceutical supply chain management (SCM) software comes into play; it helps to plan, implement, and monitor the flow of products from their point of origin to their point of consumption.

In the pharmaceutical industry, supply chain management encompasses the transportation of raw materials, active ingredients, finished products, and medical devices from manufacturers to distributors, wholesalers, pharmacies, and healthcare facilities. With the use of pharmaceutical supply chain management software, stakeholders can achieve greater transparency, leading to more efficient product delivery.

By automating time-consuming supply chain-related tasks, pharmaceutical supply chain solutions enable pharmaceutical manufacturers, distributors, wholesalers, pharmacies, and medical professionals to optimize workflows, leverage business intelligence, reduce costs, and enhance the delivery of essential drugs to patients. This includes the management of supply chain hazards such as natural disasters, interruptions, and counterfeit products. Moreover, in order to minimize these risks, it is essential to implement risk management techniques such as contingency planning and supplier diversity.

GROWTH ENABLERS

Key enablers of the global pharmaceutical supply chain management market growth: 

  • Increasing application of cloud computing systems in healthcare
    • The pharmaceutical industry is switching to cloud computing tools to enhance supply chain management (SCM). 
    • Cloud-based applications have several advantages, including increased flexibility, scalability, visibility, agility, and robustness. Cloud-based SCM systems, in this regard, offer rapid data gathering and access to data from different locations across the world, allowing multi-national warehousing operations to run smoothly. 
    • For example, SaaS-based automated dispatch management systems aid in the transmission of vital pick-up and delivery information, lowering transportation costs by transferring business to the most knowledgeable vendors by connecting ocean carriers and third-party logistics providers (3PLs).
  • Adoption of GS1 standard system
  • Growing pressure to reduce healthcare costs
  • Surging demand for pharmaceuticals products
  • High prevalence of drug counterfeiting in the pharma industry

GROWTH RESTRAINTS

Key growth restraining factors of the global pharmaceutical supply chain management market:
  • Stringent regulations in healthcare data exchange
  • High operational cost of healthcare SCM software
    • The global pharmaceutical supply chain management market faces limitations due to the exorbitant expenses associated with implementing and maintaining cloud-based SCM software systems. 
    • This can be particularly challenging for small and medium-sized pharmaceutical companies, which may lack the financial resources to invest in expensive software solutions, hindering their ability to improve and modernize their supply chain processes. 
    • Beyond the initial prices of software deployment, ongoing expenses related to maintaining, updating, and providing technical support for cloud-based SCM software can also be costly.
  • Technical problems associated with SCM software
  • Security issues in weak SCM links
To Know More About This Report, Request a Free Sample Copy

KEY MARKET TRENDS

Global Pharmaceutical Supply Chain Management Market | Major Market Trends

  • Blockchain use in the pharmaceutical sector is still in its early stages, with many of its applications yet undiscovered and associated technologies being improved, developed, and promoted. To prepare global health systems for future health crises, the pharmaceutical sector is now turning to new and emerging technologies such as blockchain. Through its shareable ledger and unalterable data, blockchain can help track a commodity’s manufacturing journey in seconds and help reduce fraud. For example, the IBM Blockchain Transparent Supply solution enables goods-specific transparency across many supply chain partners.
  • The clinically integrated pharmaceutical supply chain is critical to cutting costs and enhancing outcome quality. To meet the demands for important medical equipment and supplies needed to treat patients, supply chain professionals must be able to analyze new procurement techniques and quickly locate new sources of supply. Clinical evidence can help doctors and supply chain stakeholders collaborate to find the best resources that provide the highest quality care at the cheapest price. The HIMSS Clinically Integrated Supply Outcomes Model (CISOM), for example, examines the supply chain maturity of health systems worldwide. CISOM is an advanced and automated health system supply chain architecture that can detect and mitigate the risk of adverse events to improve patient quality and safety.

MARKET SEGMENTATION

Market Segmentation – Component and Deployment Mode – Market by Component:
  • Service
    • The service segment dominated the component category in 2022. 
    • The scope of supply chain services encompasses a range of critical functions, including planning and forecasting, inventory management, logistics management, supply chain data management, demand management, replenishment services, and supply planning.
    • By leveraging these services, businesses can access real-time insights and valuable recommendations that help to reduce the time required to mitigate disruptions, from days to just hours. 
    • Furthermore, supply chain service providers help to minimize the costs, risks, and time associated with managing new suppliers and responding promptly to any issues that may arise. Their ability to offer actionable intelligence and rapid response times is a key asset for businesses seeking to optimize their supply chain operations.
  • Solution
Market by Deployment Mode: 
  • On-Premise
  • Cloud-Based
    • Cloud-based is the fastest-growing deployment mode in the global pharmaceutical supply chain management market. 
    • Cloud computing benefits are proven successful and reasonable for small and medium-sized companies (SMEs). Also, smaller enterprises may integrate new technology faster than bigger organizations, giving them a competitive edge. 
    • Cloud computing solutions provide usability, mobility, and service agreements that allow smaller businesses to swiftly implement cloud investments and create ROI-based apps to assist SMEs in meeting regulatory standards, improving security, and lowering overhead and capital expenses. To centralize content management, customer support, and messaging, SMEs frequently used apps to view and update documents.
    • Since the advent of the COVID-19 pandemic, the cloud migration of essential services has increased. Moreover, in the last few years, cloud computing has gradually shifted from an option for healthcare providers to a business necessity.

GEOGRAPHICAL STUDY

Geographical Study Based on Four Major Regions:
  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Nordic Countries, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Australia & New Zealand, and Rest of Asia-Pacific
    • Asia-Pacific is set to be the fastest-growing and dominating region in the global pharmaceutical supply chain management market during the forecasting period.
    • The demand for pharmaceutical products in the Asia-Pacific is rising due to the growing population, urbanization, an increase in chronic diseases and disorders, as well as investments in the healthcare sector. 
    • The region’s sizable pharmaceutical industry further increases the need for supply chain management systems in order to securely deliver completed medicines to customers. Additionally, market participants for supply chain management are also strengthening their position in the Asia-Pacific, with suppliers such as IBM, SAP, and Oracle establishing offices and facilities in the region. As a result, their regional sales have increased, thus fueling the expansion of the Asia-Pacific pharmaceutical supply chain management market. 
  • Rest of World: Latin America, the Middle East & Africa

MAJOR PLAYERS

Major players in the global pharmaceutical supply chain management market:

  • SAP SE 
  • Jump Technologies Inc
  • McKesson Corporation
  • Infor
  • Oracle Corporation

Key strategies adopted by some of these companies:

  • In May 2022, Vizient and RISCS jointly launched a pilot program aimed at enhancing the resilience of the pharmaceutical supply chain. The program involves the use of a rating system to assess key components that contribute to a resilient supply chain, and to promote greater transparency throughout the process.
  • In May 2020, IBM Corporation launched Rapid Supplier Connect. The newly launched product, a blockchain network, was aimed at strengthening the medical supply chain during COVID-19.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments AnalyzedComponent and Deployment Mode
Geographies AnalyzedNorth America, Europe, Asia-Pacific, and Rest of World
Companies AnalyzedMcKesson Corporation, Tecsys Inc, Infor, Oracle Corporation, Cardinal Health, SAP SE, Arvato Supply Chain Solutions, Terso Solution, Logitag Systems, Vizient Inc, Manhattan Associates, Spectrum Health, Epicor Software Corporation, Global Healthcare Exchange LLC, Jump Technologies

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. INCREASING APPLICATION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
      2. ADOPTION OF GS1 STANDARD SYSTEM
      3. GROWING PRESSURE TO REDUCE HEALTHCARE COSTS
      4. SURGING DEMAND FOR PHARMACEUTICALS PRODUCTS
      5. HIGH PREVALENCE OF DRUG COUNTERFEITING
    2. KEY RESTRAINTS
      1. STRINGENT REGULATIONS IN HEALTHCARE DATA EXCHANGE
      2. HIGH OPERATIONAL COSTS OF HEALTHCARE SCM SOFTWARE
      3. TECHNICAL PROBLEMS ASSOCIATED WITH SCM SOFTWARE
      4. SECURITY ISSUES IN WEAK SCM LINKS
  4. KEY ANALYTICS
    1. KEY TECHNOLOGY TRENDS
    2. PORTER’S FIVE FORCES ANALYSIS 
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
    4. MARKET CONCENTRATION ANALYSIS 
    5. MARKET MATURITY ANALYSIS 
  5. MARKET BY COMPONENT
    1. SOLUTION
      1. TRANSPORTATION MANAGEMENT SYSTEM
      2. PLANNING & ANALYTICS
      3. WAREHOUSE & INVENTORY MANAGEMENT SYSTEM
      4. PROCUREMENT & SOURCING
      5. MANUFACTURING EXECUTION SYSTEM
    2. SERVICE
      1. PROFESSIONAL SERVICES
      2. MANAGED SERVICES
  6. MARKET BY DEPLOYMENT MODE
    1. ON-PREMISE
    2. CLOUD-BASED
  7. GEOGRAPHICAL ANALYSIS 
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
      3. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
      4. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
      6. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
        2. CANADA
          1. CANADA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
      3. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
      4. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
      6. COUNTRY ANALYSIS
        1. UNITED KINGDOM
          1. UNITED KINGDOM PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
        2. GERMANY
          1. GERMANY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
        3. FRANCE
          1. FRANCE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
        4. ITALY
          1. ITALY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
        5. SPAIN
          1. SPAIN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
        6. NORDIC COUNTRIES
          1. NORDIC COUNTRIES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
        7. REST OF EUROPE
          1. REST OF EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
      3. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
      4. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
      6. COUNTRY ANALYSIS 
        1. CHINA
          1. CHINA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
        2. JAPAN
          1. JAPAN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
        3. INDIA
          1. INDIA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
        4. SOUTH KOREA
          1. SOUTH KOREA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
        5. AUSTRALIA & NEW ZEALAND
          1. AUSTRALIA & NEW ZEALAND PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
        6. REST OF ASIA-PACIFIC
          1. REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
      3. REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
      4. REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
      6. REGIONAL ANALYSIS
        1. LATIN AMERICA
          1. LATIN AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
        2. MIDDLE EAST & AFRICA
          1. MIDDLE EAST & AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
  8. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. PRODUCT LAUNCHES
      2. PARTNERSHIPS
    2. COMPANY PROFILES
      1. ARVATO SUPPLY CHAIN SOLUTIONS
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      2. CARDINAL HEALTH
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES  
      3. EPICOR SOFTWARE CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      4. GLOBAL HEALTHCARE EXCHANGE LLC
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES  
      5. INFOR
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES 
      6. JUMP TECHNOLOGIES
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      7. LOGITAG SYSTEMS
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      8. MANHATTAN ASSOCIATES
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES 
      9. MCKESSON CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES  
      10. ORACLE CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES 
      11. SAP SE
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES  
      12. SPECTRUM HEALTH
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      13. TECSYS INC
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES 
      14. TERSO SOLUTION
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES 
      15. VIZIENT INC
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT

TABLE 2: PRIMARY FACTORS CONTRIBUTING TO THE WIDESPREAD PRESENCE OF COUNTERFEIT GOODS

TABLE 3: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 4: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 5: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 6: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 7: GLOBAL TRANSPORTATION MANAGEMENT SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 8: GLOBAL TRANSPORTATION MANAGEMENT SYSTEM MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 9: GLOBAL PLANNING & ANALYTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 10: GLOBAL PLANNING & ANALYTICS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 11: GLOBAL WAREHOUSE & INVENTORY MANAGEMENT SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 12: GLOBAL WAREHOUSE & INVENTORY MANAGEMENT SYSTEM MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 13: GLOBAL PROCUREMENT & SOURCING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 14: GLOBAL PROCUREMENT & SOURCING MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 15: GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 16: GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 17: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 18: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 19: GLOBAL PROFESSIONAL SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 20: GLOBAL PROFESSIONAL SERVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 21: GLOBAL MANAGED SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 22: GLOBAL MANAGED SERVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 23: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 24: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 25: GLOBAL ON-PREMISE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 26: GLOBAL ON-PREMISE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 27: GLOBAL CLOUD-BASED MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 28: GLOBAL CLOUD-BASED MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 29: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 30: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 31: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 32: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 33: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK

TABLE 34: KEY PLAYERS OPERATING IN NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET

TABLE 35: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 36: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 37: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK

TABLE 38: KEY PLAYERS OPERATING IN EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET

TABLE 39: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 40: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 41: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK

TABLE 42: KEY PLAYERS OPERATING IN ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET

TABLE 43: REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 44: REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 45: REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK

TABLE 46: KEY PLAYERS OPERATING IN REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET

TABLE 47: LIST OF PRODUCT LAUNCHES

TABLE 48: LIST OF PARTNERSHIPS

LIST OF FIGURES 

FIGURE 1: KEY TECHNOLOGY TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS  

FIGURE 3: GROWTH PROSPECT MAPPING FOR NORTH AMERICA

FIGURE 4: GROWTH PROSPECT MAPPING FOR EUROPE

FIGURE 5: GROWTH PROSPECT MAPPING FOR ASIA-PACIFIC

FIGURE 6: GROWTH PROSPECT MAPPING FOR REST OF WORLD

FIGURE 7: MARKET MATURITY ANALYSIS  

FIGURE 8: MARKET CONCENTRATION ANALYSIS  

FIGURE 9: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2022

FIGURE 10: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2032 (IN $ MILLION)

FIGURE 11: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY SOLUTION, IN 2022

FIGURE 12: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY TRANSPORTATION MANAGEMENT SYSTEM, 2023-2032 (IN $ MILLION)

FIGURE 13: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PLANNING & ANALYTICS, 2023-2032 (IN $ MILLION)

FIGURE 14: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY WAREHOUSE & INVENTORY MANAGEMENT SYSTEM, 2023-2032 (IN $ MILLION)

FIGURE 15: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROCUREMENT & SOURCING, 2023-2032 (IN $ MILLION)

FIGURE 16: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANUFACTURING EXECUTION SYSTEM, 2023-2032 (IN $ MILLION)

FIGURE 17: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2032 (IN $ MILLION)

FIGURE 18: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2022

FIGURE 19: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROFESSIONAL SERVICES, 2023-2032 (IN $ MILLION)

FIGURE 20: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANAGED SERVICES, 2023-2032 (IN $ MILLION)

FIGURE 21: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODE, IN 2022

FIGURE 22: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY ON-PREMISE, 2023-2032 (IN $ MILLION)

FIGURE 23: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY CLOUD-BASED, 2023-2032 (IN $ MILLION)

FIGURE 24: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)

FIGURE 25: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 26: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 27: CANADA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 28: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 29: UNITED KINGDOM PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 30: GERMANY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 31: FRANCE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 32: ITALY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 33: SPAIN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 34: NORDIC COUNTRIES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 35: REST OF EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 36: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 37: CHINA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 38: JAPAN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 39: INDIA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 40: SOUTH KOREA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 41: AUSTRALIA & NEW ZEALAND PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 42: REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 43: REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)

FIGURE 44: LATIN AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FIGURE 45: MIDDLE EAST & AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

FAQ’s

FAQs

As of 2022, the global pharmaceutical supply chain management market was valued at $2302.87 million.

GS1 global standards enable pharmaceutical producers, distributors, and healthcare providers to adhere to safety procedures and protocols, which are crucial to ensuring public trust and confidence in medical goods such as vaccines, as well as the ability to properly roll out these vaccinations.

Cloud-based is the largest revenue-generating deployment mode in the global pharmaceutical supply chain management market.

Service is anticipated to be the fastest-growing component in the global pharmaceutical supply chain management market.